Skip to main content

Table 7 IVE for all cases and for targeted groups only by age and strain

From: Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)

   

Influenza-positive

Influenza-negative

Adjusted IVE(*)

Population

Strain

Age

Total

Vaccinated

Total

Vaccinated

Percent

(95% CI)

P-value

Overall

Any

Any

2895

279

7245

938

27 (15, 38)

 
 

<65 y

2013

84

5558

265

27 (−1, 48)

0.804

 

≥65 y

882

195

1687

673

25 (3, 43)

 

A (H1N1) pdm09

Any

76

7

7245

938

39 (−68, 78)

 
 

<65 y

66

6

5558

265

2 (−138, 60)

0.346

 

≥65 y

10

1

1687

673

99 (1, 100)

 

A (H3N2)

Any

1840

221

7245

938

25 (13, 35)

 
 

<65 y

1124

46

5558

265

31 (1, 51)

0.703

 

≥65 y

716

175

1687

673

19 (−10, 40)

 

B/Yamagata

Any

108

9

7245

938

41 (−110, 84)

 
 

<65 y

73

3

5558

265

7 (−178, 69)

0.203

 

≥65 y

35

6

1687

673

73 (−38, 95)

 

B/Victoria

Any

618

25

7245

938

43 (−15, 71)

 
 

<65 y

596

24

5558

265

27 (−14, 54)

0.191

 

≥65 y

22

1

1687

673

89 (40, 98)

 

Targeted groups only

Any

Any

2314

256

4723

869

27 (16, 37)

 
 

<65 y

1432

61

3036

196

37 (0, 47)

0.657

 

≥65 y

882

195

1687

673

25 (3, 43)

 

A (H1N1) pdm09

Any

54

7

4723

869

18 (−142, 72)

 
 

<65 y

44

6

3036

196

−62 (−303, 35)

0.423

 

≥65 y

10

1

1687

673

99 (1, 100)

 

A (H3N2)

Any

1572

214

4723

869

23 (9, 34)

 
 

<65 y

856

39

3036

196

27 (−7, 50)

0.485

 

≥65 y

716

175

1687

673

19 (−10, 40)

 

B/Yamagata

Any

63

7

4723

869

72 (8, 92)

 
 

<65 y

28

1

3036

196

65 (−35, 91)

0.037

 

≥65 y

35

6

1687

673

73 (−38, 95)

 

B/Victoria

Any

449

14

4723

869

66 (3, 80)

 
 

<65 y

427

13

3036

196

41 (10, 62)

0.262

 

≥65 y

22

1

1687

673

89 (40, 98)

 
  1. (*) .IVE was obtained in each case using the same model (described in the ‘Methods’ section) but restricting it by strain, age or targeted groups.. P-value obtained comparing patients <65 y and ≥ 65 y